Inst Diagnosti (INDISA) - Total Liabilities
Based on the latest financial reports, Inst Diagnosti (INDISA) has total liabilities worth CL$191.22 Billion CLP (≈ $213.85 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore INDISA shareholders equity momentum to track the company's year-over-year net asset growth rate.
Inst Diagnosti - Total Liabilities Trend (2014–2025)
This chart illustrates how Inst Diagnosti's total liabilities have evolved over time, based on quarterly financial data. See Inst Diagnosti (INDISA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Inst Diagnosti Competitors by Total Liabilities
The table below lists competitors of Inst Diagnosti ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Curro Hol
JSE:COH
|
South Africa | ZAC5.25 Billion |
|
Hey-Song Corp
TW:1234
|
Taiwan | NT$5.51 Billion |
|
Clean Energy Fuels Corp
NASDAQ:CLNE
|
USA | $473.17 Million |
|
Zhejiang Wandekai Fluid Equipment Technology Co. Ltd. A
SHE:301309
|
China | CN¥183.63 Million |
|
Bingshan Refrigeration & Heat Transfer Technologies Co Ltd
SHE:000530
|
China | CN¥4.11 Billion |
|
Dongrui Food Group Co Ltd
SHE:001201
|
China | CN¥2.81 Billion |
|
Nantex Industry Co Ltd
TW:2108
|
Taiwan | NT$1.88 Billion |
|
Nexus Real Estate Investment Trust
TO:NXR-UN
|
Canada | CA$1.58 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Inst Diagnosti's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INDISA market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inst Diagnosti's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inst Diagnosti (2014–2025)
The table below shows the annual total liabilities of Inst Diagnosti from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CL$201.84 Billion ≈ $225.72 Million |
+23.61% |
| 2024-12-31 | CL$163.28 Billion ≈ $182.60 Million |
-5.38% |
| 2023-12-31 | CL$172.56 Billion ≈ $192.98 Million |
+0.75% |
| 2022-12-31 | CL$171.26 Billion ≈ $191.53 Million |
+26.20% |
| 2021-12-31 | CL$135.71 Billion ≈ $151.77 Million |
+38.62% |
| 2020-12-31 | CL$97.90 Billion ≈ $109.49 Million |
+13.08% |
| 2019-12-31 | CL$86.58 Billion ≈ $96.82 Million |
-0.96% |
| 2018-12-31 | CL$87.42 Billion ≈ $97.76 Million |
-3.79% |
| 2017-12-31 | CL$90.86 Billion ≈ $101.61 Million |
-0.33% |
| 2016-12-31 | CL$91.16 Billion ≈ $101.95 Million |
+15.85% |
| 2015-12-31 | CL$78.69 Billion ≈ $88.00 Million |
+27.89% |
| 2014-12-31 | CL$61.53 Billion ≈ $68.81 Million |
-- |
About Inst Diagnosti
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more